Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,192 | $2,518 | $1,334 | $1,380 |
| - Cash | $164 | $56 | $141 | $233 |
| + Debt | $25 | $25 | $23 | $23 |
| Enterprise Value | $1,054 | $2,487 | $1,216 | $1,170 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$247 | -$237 | -$214 | -$158 |
| % Margin | – | – | – | – |
| Net Income | -$259 | -$246 | -$222 | -$169 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.73 | -2.92 | -3.26 | -2.68 |
| % Growth | 6.5% | 10.4% | -21.6% | – |
| Operating Cash Flow | -$210 | -$195 | -$178 | -$121 |
| Capital Expenditures | -$6 | -$16 | -$9 | -$8 |
| Free Cash Flow | -$216 | -$211 | -$187 | -$129 |